IMS Health, a provider of market intelligence to the pharmaceutical and healthcare industries, launches the IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the USA, known as “aggregate spend” reporting regulations.
